Adma Biologics (ADMA) Current Deferred Revenue (2014 - 2025)
Adma Biologics (ADMA) posted Current Deferred Revenue of $143000.0 for Q2 2025, little changed on a QoQ basis from $143000.0 in Q1 2025, and down 87.35% year-over-year from $1.1 million in Q2 2024.
Adma Biologics (ADMA) Current Deferred Revenue (2014 - 2025) Analysis & Trends
Adma Biologics' Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $143000.0 for Q2 2025.
- Quarterly Current Deferred Revenue fell 87.35% year-over-year to $143000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $143000.0 (down 87.35% YoY) and the FY2024 annual result came in at $143000.0, down 21.43% from the prior year.
- Current Deferred Revenue was $143000.0 for Q2 2025 at Adma Biologics, roughly flat from $143000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $1.1 million in Q2 2024 and bottomed at $142834.0 in Q1 2021.
- A 5-year average of $254074.4 and a median of $142834.0 in 2021 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue surged 691.13% — and 2025, when it tumbled 87.35%.
- Adma Biologics' Current Deferred Revenue stood at $142834.0 in 2021, then climbed by 0.12% to $143000.0 in 2022, then increased by 27.27% to $182000.0 in 2023, then declined by 21.43% to $143000.0 in 2024, then changed by 0.0% to $143000.0 in 2025.
- Business Quant data shows ADMA's Current Deferred Revenue at $143000.0 in Q2 2025, $143000.0 in Q1 2025, and $143000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 182,000.00 |
| Sep 30, 2023 | 142,834.00 |
| Jun 30, 2023 | 142,834.00 |
| Mar 31, 2023 | 142,834.00 |
| Dec 31, 2022 | 143,000.00 |
| Sep 30, 2022 | 142,834.00 |
| Jun 30, 2022 | 142,834.00 |
| Mar 31, 2022 | 142,834.00 |
| Dec 31, 2021 | 142,834.00 |
| Sep 30, 2021 | 142,834.00 |
| Jun 30, 2021 | 142,834.00 |
| Mar 31, 2021 | 142,834.00 |
| Dec 31, 2020 | 142,834.00 |
| Sep 30, 2020 | 142,834.00 |